β2-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro

Journal of Molecular Biology

Volumn 313, Issue 3, 2001, Pages 559-571

  Kad, Neil M ^a   Thomson, Neil H ^a   Smith, David P ^a   Smith, D Alastair ^a   Radford, Sheena E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Amyloid; Atomic force microscopy; Deamidation; Tapping mode; 2 microglobulin

Indexed keywords

AMYLOID; ASPARAGINE; ASPARTIC ACID; BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; DEAMINATION; HEMODIALYSIS; IN VITRO STUDY; IONIC STRENGTH; KINETICS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY;

EID: 0035955555     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5071     Document Type: Article

References (53)

1. Amyloidosis
2. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix
3. On the binding of Congo red by amyloid
4. Thioflavine-T interaction with amyloid β-sheet structures
5. The protofilament substructure of amyloid fibrils
6. Polymorphic fibrillar assembly of human amylin
7. Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy
8. Ultrastructural organization of amyloid fibrils by atomic force microscopy
9. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing
10. Watching amyloid fibrils grow by time-lapse atomic force microscopy
11. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein
12. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
13. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
14. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
15. A new form of amyloid protein associated with chronic-hemodialysis was identified as β-2-microglobulin
16. β-2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils
17. Lysine-specific cleavage of β-2-microglobulin in amyloid deposits associated with hemodialysis
18. Purification and complete amino acid sequence of novel β-2-microglobulin
19. β-2-microglobulin isoforms in healthy individuals and in amyloid deposits
20. Electron-microscopic and immunohistochemical study of β-2-microglobulin-related amyloidosis
21. Ultrastructure of familial amyloid polyneuropathy amyloid fibrils: Examination with high-resolution electron microscopy
22. Dialysis arthropathy of the hip
23. Collagen-binding affinity of β-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis
24. 2m amyloid in dialysis patients
25. Structure of the human class I histocompatibity antigen, HLA-A2
26. Serum levels of β-2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis
27. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro
28. Partially unfolded states of β-2-microglobulin and amyloid formation in vitro
29. Formation of amyloid-like substance from β-2-microglobulin in vitro
30. Kidney dialysis-associated amyloidosis: A molecular role for copper in fiber formation
31. In vitro formation of amyloid fibrils from intact β-2-microglobulin
32. Ultrastructural organization of hemodialysis-associated β-2-microglobulin amyloid fibrils
33. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module
34. Amyloid fibril formation by an SH3 domain
35. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
36. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains
37. Polymerization of irttact β-2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis
38. Seeding one-dimensional crystallization of amyloid - A pathogenic mechanism in Alzheimers-disease and scrapie
39. Amyloid β-protein fibrillogenesis - Detection of a protofibrillar intermediate
40. A role for destabilizing amino-acid replacements in light-chain amyloidosis
41. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity
42. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis
43. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates
44. The acidmediated denatuation pathway of transthyretin yields a conformation intermediate that can self-assemble into amyloid
45. Role of the single disulphide bond of β-2-microglobulin in amyloidosis in vitro
46. Assembly of Aβ amyloid protoflbrils: An in vitro model for a possible early event in Alzheimer's disease
47. Production and crystallization of MHC class I B allele single peptide complexes
48. 1H NMR assignments and secondary structure of human β-2-microglobulin in solution
49. Isolation and properties of a low molecular weight β-2-globulin occurring in human biological fluids
50. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants
51. A method for directly fitting the time derivative of sedimentation velocity data and an alternative algorithm for calculating sedimentation coefficient distribution functions
52. Swiss-model and the Swiss-PDB viewer: An environment for comparative protein modelling